SIZE XSSIZE SMSIZE MDSIZE LG

BCOP Self-Study Online Module Bundle

The 2019 Self-Study Online Bundle provides new high quality professional development education and features a series of current articles from primary oncology literature. BCOP Self-Study Modules are on-demand and allow you to review at your convenience.

Highlights

  • Leading experts from a variety of specialties and settings
  • Therapeutic developments translated into case-based reviews
  • Application of information to practice based scenarios
  • Credit given per module – choose one or all

Credits:

  • Up to 15 hours of BCOP and ACPE credit with completion of both releases.
  • BCOP credits are available for 2019 Release I to earn until August 28, 2019.
  • BCOP credits are available for 2019 Release II to earn until February 28, 2020.

2019 BCOP Self-Study Online Modules – Release I

  • Module 1: Updates in Breast Cancer (1.0 BCOP/ACPE)
  • Module 2: Hepatitis B (2.0 BCOP/ACPE)
  • Module 3: Radiation Oncology (2.5 BCOP/ACPE)
  • Module 4: Complementary and Alternative Medicine and Mindfulness (2.0 BCOP/ACPE)

Learn more about 2019 BCOP Online Module Release I.

 

2019 BCOP Self-Study Online Modules – Release II

  • Module 5: Chronic Graft-versus-Host Disease (2.5 BCOP/ACPE)
  • Module 6: Adolescent and Young Adult (AYA) (2.5 BCOP/ACPE)
  • Module 7: Pharmacy Accreditation (2.5 BCOP/ACPE)

Learn more about 2019 BCOP Online Module Release II.

Case Study questions will count towards the overall test score for the BCOP credit. Your results in the Case Studies and the Post-test questions will determine your total score which still must meet the 75% threshold for passing to earn BCOP credit.

Target Audience

This activity is intended for intermediate/advanced hematology/oncology pharmacists.

Activity Type:

Application

Credit Designation

Accreditation Statement:

logo acpeThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. ACPE credit for Release I must be claimed by February 28, 2020 and ACPE credit for Release II must be claimed by August 31, 2022.

education speaker bpslogoThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certification oncology credit (BCOP). A BCOP statement of credit will be issued only upon completion of a post-activity evaluation form, case-study and post-test, with a combined passing grade of 75% or greater is achieved. BCOP credits for Release I are available until August 28, 2019 and BCOP credits for Release II are available until February 28, 2020.

Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.

Reported Areas of Conflict: Planners and Managers Hematology/Oncology Pharmacy Association does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced, objective, and scientifically rigorous. Occasionally, authors may express opinions that represent their own viewpoint. Conclusions drawn by participants should be derived from objective analysis of scientific data. Unlabeled/unapproved uses of drugs. All faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs and devices.

$300 (member) / $420 (non-member)

Purchase now (Purchase provides access to 2019 Release I and Release II)

The 2019 BCOP Self-Study Online Module Bundle is also a part of the 2019 BCOP Program Bundle. If you’ve already purchased the 2019 BCOP Program Bundle, you can access your Self-Study Modules in My Education Library.


The 2018 Self-Study Online Module Bundle provides new high quality professional development education and features a series of current articles from primary oncology literature on demand and at your convenience.

  • Leading experts from a variety of specialties and settings
  • Therapeutic developments translated into case-based reviews
  • Application of information to practice based scenarios
  • Credit given per module – choose one or all

Credits: Up to 15 hours of BCOP and ACPE credit with completion of both releases.
BCOP credits are available for 2018 Release I to earn until October 27, 2018.

BCOP credits are available for 2018 Release II to earn until March 29, 2019.

2018 Release I

  • Module 1: Hodgkin Lymphoma: Where Do All the Pieces Fit? (1.5 BCOP/ACPE)
  • Module 2: Updates in the Treatment of Acute Myeloid Leukemia (2.5 BCOP/ACPE)
  • Module 3: Biomarkers in Immunotherapy (1.5 BCOP/ACPE)
  • Module 4: Treatment of NSCLC with a Focus on Newer Therapies (2.5 BCOP/ACPE)

2018 Release II

  • Module 5: Advances in the Diagnosis and Treatment of Acute Graft-versus-Host Disease (2 BCOP/ACPE)
  • Module 6: Anticoagulation – NOAC Agents in Oncology and Reversal Agents (2 BCOP/ACPE)
  • Module 7: New Updates in Gastric and Gastroesophageal Junction Adenocarcinoma (1.5 BCOP/ACPE)
  • Module 8: Melanoma - Pharmacoeconomics (1.5 BCOP/ACPE)

Learn more about 2018 BCOP Online Module Release II.

Each module will include access to articles, pre-assessment questions, patient cases and/or case—based discussion/questions and the BCOP posttest. Your purchase includes all four modules. You may choose to complete all 4 modules or select modules individually and still receive BCOP credit for modules which achieve passing scores. Participants will complete the patient case/case-based questions and the posttest for each module and must achieve a 75% combined passing grade to obtain BCOP Recertification credit for that module.

logo acpeThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certification oncology credit (BCOP). A BCOP statement of credit will be issued only upon completion of a post-activity evaluation form and post-test, with a passing grade of 75% achieved. BCOP credits for 2018 Release I are available until October 27, 2018 and BCOP credits for 2018 Release II are available until March 29, 2019.

education speaker bpslogoThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certification oncology credit (BCOP). A BCOP statement of credit will be issued only upon completion of a post-activity evaluation form and post-test, with a passing grade of 75% achieved. BCOP credits for 2018 Release I are available until October 27, 2018 and BCOP credits for 2018 Release II are available until March 29, 2019.

Target Audience

This activity is intended for intermediate/advanced hematology/oncology pharmacists.

Activity Type:

Application

Accreditation Statement:

Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.

Reported Areas of Conflict: Planners and Managers Hematology/Oncology Pharmacy Association does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced, objective, and scientifically rigorous. Occasionally, authors may express opinions that represent their own viewpoint. Conclusions drawn by participants should be derived from objective analysis of scientific data. Unlabeled/unapproved uses of drugs. All faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs and devices.

xs
sm
md
lg